UNCLAIMED
Kalderos
Overview
Kalderos is a U.S.-based software company founded in 2016, specializing in healthcare software solutions that address drug discount management and the complexities of pricing in the pharmaceutical industry. The company has published several documents that explore current industry pressures and the implications of legislation such as the Inflation Reduction Act on drug pricing and the 340B program. Their research reports emphasize the increasing significance of accurate data for pharmaceutical manufacturers, particularly in managing commercial contracts and avoiding duplicate discounts. Kalderos highlights the challenges posed by overlapping discount programs, including 340B and commercial rebates, which can complicate pricing strategies for manufacturers. The company’s white papers and reports provide insights into the evolving landscape of drug discount management, underscoring the importance of effective data utilization to navigate the complexities of the market. Through its publications, Kalderos aims to inform stakeholders about the critical factors influencing drug pricing and discount strategies in the healthcare sector.